JFG
MXCT icon

Jefferies Financial Group’s MaxCyte MXCT Stock Holding History

Jefferies Financial Group’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.6K Buy
15,972
+5,972
+60% +$5.95K ﹤0.01% 1601
2026
Q1 		$7.03K Hold
10,000
– – ﹤0.01% 1689
2025
Q4 		$15.5K Buy
+10,000
New +$16K ﹤0.01% 1809

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Jefferies Financial Group's MXCT Position: Q2 2026 in Review

Jefferies Financial Group increased its MaxCyte (MXCT) stake by 60% in Q2 2026, buying an estimated $5.95K and bringing the position to 15,972 shares worth $19.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1601.

Jefferies Financial Group first reported a position in MXCT in Q4 2025 and has held it in 3 quarters since. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Jefferies Financial Group held 15,972 shares of MaxCyte worth $19.6K as of Q2 2026.
  • Jefferies Financial Group bought 5,972 MaxCyte shares in Q2 2026, an estimated $5.95K.
  • MaxCyte made up ﹤0.01% of Jefferies Financial Group's portfolio in Q2 2026, its #1601 holding.
  • Jefferies Financial Group first reported a position in MaxCyte in Q4 2025 and has held it in 3 quarters since.
  • 122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.